U-Blot® Research Grade AldastotugCat. No. WA1048Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade AldastotugCat. No. WA1048
U-Blot® Research Grade AldaferminCat. No. WA1047
U-Blot® Research Grade ALD1910Cat. No. WA1046
U-Blot® Research Grade alcestobartCat. No. WA1045
U-Blot® Research Grade Albutrepenonacog alfaCat. No. WA1044
U-Blot® Research Grade Albipagrastim AlfaCat. No. WA1043
U-Blot® Research Grade Albinterferon alfa-2bCat. No. WA1042
U-Blot® Research Grade AlbiglutideCat. No. WA1041
U-Blot® Research Grade AlacizumabCat. No. WA1040
U-Blot® Research Grade AJW200Cat. No. WA1039
U-Blot® Research Grade AfliberceptCat. No. WA1038
U-Blot® Research Grade AfliberceptCat. No. WA1037